Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 29, Issue 4, 1998, Pages 779-785

  Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIBODY; HEPATITIS VACCINE; INACTIVATED VACCINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; HEPATITIS A; HUMAN; IMMUNOLOGY; SAFETY; THAILAND;

ADOLESCENT; ADULT; CONSUMER PRODUCT SAFETY; HEPATITIS A; HEPATITIS ANTIBODIES; HUMANS; THAILAND; VACCINES, INACTIVATED; VIRAL HEPATITIS VACCINES;

EID: 0032227712     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. ACIP. Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45 (RR-15): 1-30.
2. Boutin JP, Buisson Y, Chapuis P, et al. Evaluation of safety and immunogenicity of a new inactivated hepatitis A vaccine in the French army. Int Rev Armed Forces Med Serv 1996; LXIX: 249-54.